Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Endo Pharma and Orion enter into oncology collaboration

Jan. 28, 2011

ALK-Abello and Torii Pharma enter license agreement for allergy immunotherapies

Jan. 28, 2011

NuVax licenses immune-gene therapeutics technology

Jan. 28, 2011

Sunshine Biopharma and Binghamton University sign agreement for Adva-27a

Jan. 27, 2011

ChemoCentryx begins phase I trial of CCX-832 under alliance with GSK

Jan. 27, 2011

Kyowa Hakko Kirin and Amgen collaborate on AMG-827

Jan. 27, 2011

GenVec and U.S. NMRC collaborate on vaccine for dengue fever

Jan. 26, 2011

Theraclone and Pfizer to codevelop antibodies against infectious disease and cancer targets

Jan. 21, 2011

Evotec and Takeda Cambridge join to identify GPCR and protease modulators

Jan. 21, 2011

Harbor BioSciences licenses three compounds to CIPI in China

Jan. 20, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...